These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 17515538)
1. Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam. Borenstein AR; Mortimer JA; Schofield E; Wu Y; Salmon DP; Gamst A; Olichney J; Thal LJ; Silbert L; Kaye J; Craig UL; Schellenberg GD; Galasko DR Neurology; 2007 May; 68(21):1764-71. PubMed ID: 17515538 [TBL] [Abstract][Full Text] [Related]
2. Tales of Pacific tangles: Cycad exposure and Guamanian neurodegenerative diseases. Friedland RP; Armon C Neurology; 2007 May; 68(21):1759-61. PubMed ID: 17515536 [No Abstract] [Full Text] [Related]
3. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Cox PA; Sacks OW Neurology; 2002 Mar; 58(6):956-9. PubMed ID: 11914415 [TBL] [Abstract][Full Text] [Related]
4. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? Ince PG; Codd GA Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818 [TBL] [Abstract][Full Text] [Related]
5. The ALS/PDC syndrome of Guam and the cycad hypothesis. Steele JC; McGeer PL Neurology; 2008 May; 70(21):1984-90. PubMed ID: 18490618 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE. Galasko D; Salmon D; Gamst A; Olichney J; Thal LJ; Silbert L; Kaye J; Brooks P; Adonay R; Craig UK; Schellenberg G; Borenstein AR Neurology; 2007 May; 68(21):1772-81. PubMed ID: 17515539 [TBL] [Abstract][Full Text] [Related]
7. A link between ALS and short residence on Guam. Majoor-Krakauer D; Mulder PG; Rowland LP; Ottman R Neurology; 2005 May; 64(10):1819-20. PubMed ID: 15911829 [No Abstract] [Full Text] [Related]
8. The ALS/PDC syndrome of Guam and the cycad hypothesis. Bradley WG; Banack SA; Cox PA Neurology; 2009 Feb; 72(5):473-4, 476; author reply 475-6. PubMed ID: 19195084 [No Abstract] [Full Text] [Related]
9. Seeking environmental causes of neurodegenerative disease and envisioning primary prevention. Spencer PS; Palmer VS; Kisby GE Neurotoxicology; 2016 Sep; 56():269-283. PubMed ID: 27050202 [TBL] [Abstract][Full Text] [Related]
10. The ALS/PDC syndrome of Guam and the cycad hypothesis. Borenstein AR; Mortimer JA; Schellenberg GD; Galasko D Neurology; 2009 Feb; 72(5):473, 476; author reply 475-6. PubMed ID: 19188582 [No Abstract] [Full Text] [Related]
11. Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989. Waring SC; Esteban-Santillan C; Reed DM; Craig UK; Labarthe DR; Petersen RC; Kurland LT Neuroepidemiology; 2004; 23(4):192-200. PubMed ID: 15272222 [TBL] [Abstract][Full Text] [Related]
12. Brain volumes in Guam dementia vs Parkinson dementia complex vs aging Chamorro adults. Kaye JA; Moore MM; Galasko D; Craig UK; Adonay R; Silbert LC Neurology; 2007 Jul; 69(2):196-9. PubMed ID: 17620553 [TBL] [Abstract][Full Text] [Related]
13. The ALS/PDC syndrome of Guam and the cycad hypothesis. Cruz-Aguado R; Shaw CA Neurology; 2009 Feb; 72(5):474, 476; author reply 475-6. PubMed ID: 19195085 [No Abstract] [Full Text] [Related]
14. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Banack SA; Cox PA Neurology; 2003 Aug; 61(3):387-9. PubMed ID: 12913204 [TBL] [Abstract][Full Text] [Related]
15. Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex. Khabazian I; Bains JS; Williams DE; Cheung J; Wilson JM; Pasqualotto BA; Pelech SL; Andersen RJ; Wang YT; Liu L; Nagai A; Kim SU; Craig UK; Shaw CA J Neurochem; 2002 Aug; 82(3):516-28. PubMed ID: 12153476 [TBL] [Abstract][Full Text] [Related]
16. Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC. Wilson JM; Petrik MS; Moghadasian MH; Shaw CA Can J Physiol Pharmacol; 2005 Feb; 83(2):131-41. PubMed ID: 15791286 [TBL] [Abstract][Full Text] [Related]
17. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex. Winton MJ; Joyce S; Zhukareva V; Practico D; Perl DP; Galasko D; Craig U; Trojanowski JQ; Lee VM Acta Neuropathol; 2006 May; 111(5):401-12. PubMed ID: 16609851 [TBL] [Abstract][Full Text] [Related]
18. Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures. Banack SA; Cox PA Neurotox Res; 2018 Jan; 33(1):24-32. PubMed ID: 28478528 [TBL] [Abstract][Full Text] [Related]